Aquavit Files Investigation of New Drug for New Botulinum Toxin
Aquavit Pharmaceuticals, Inc. has submitted to the U.S. FDA an Investigation of New Drug package for a new botulinum toxin, DTX-021.
Tag: Aquavit Pharmaceuticals
All
Popular
All
LatestSorry, No Posts Found
All
Latest
Study to Test AI Burn Assessment for Head, Hand, and Foot Injuries
A UK clinical study will evaluate Spectral AI’s DeepView System in anatomically complex burn areas, with a burns and plastic surgeon leading the first study site.
